Search

Your search keyword '"Golino, Paolo"' showing total 112 results

Search Constraints

Start Over You searched for: Author "Golino, Paolo" Remove constraint Author: "Golino, Paolo" Topic humans Remove constraint Topic: humans
112 results on '"Golino, Paolo"'

Search Results

1. Safety and feasibility of balloon aortic valvuloplasty in non-TAVI centers: The 'BAV for life' experience

2. 2021 ESC/EACTS Guidelines for the management of valvular heart disease

3. Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: Observational study using prospectively collected registry data

4. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era

5. Prognostic Factors in Patients With Stemi Undergoing Primary PCI in the Clopidogrel Era: Role of Dual Antiplatelet Therapy at Admission and the Smoking Paradox on Long-Term Outcome

6. Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF

7. [New antithrombotic drugs in cardiovascular disease]

8. Neutrophil to lymphocyte ratio predicts permanent pacemaker implantation in TAVR patients

9. Recommendations in pre-procedural imaging assessment for transcatheter aortic valve implantation intervention: Italian Society of Cardiology (SIC)–Italian Society of Medical and Interventional Radiology (SIRM) position paper part 1 (Clinical Indication and Basic Technical Aspects, Heart Team, Role of Echocardiography)

10. Arrhythmic CArdiac DEath in MYotonic dystrophy type 1 patients (ACADEMY 1) study: the predictive role of programmed ventricular stimulation

11. An unusual case of retrobulbar haemorrhage following a transoesophageal echocardiogram: a rare but a potential severe complication

12. Lipid Accumulation in Hearts Transplanted From Nondiabetic Donors to Diabetic Recipients

13. Cardioinhibitory syncope with asystole during nitroglycerin potentiated head up tilt test: prevalence and clinical predictors

14. The pharmacology of anticoagulant drug treatment options in COVID-19 patients: reviewing real-world evidence in clinical practice

15. Inappropriate shocks due to air entrapment in patients with subcutaneous implantable cardioverter-defibrillator: A meta-summary of case reports

16. Glycated ACE2 reduces anti-remodeling effects of renin-angiotensin system inhibition in human diabetic hearts

17. Prevalence and clinical predictors of inappropriate direct oral anticoagulant dosage in octagenarians with atrial fibrillation

18. Retrieval of a leadless transcatheter pacemaker from the right pulmonary artery: A case report

19. Clinical Performance of Apixaban vs. Vitamin K Antagonists in Patients with Atrial Fibrillation Undergoing Direct Electrical Current Cardioversion: A Prospective Propensity Score-Matched Cohort Study

20. Patent foramen ovale with complex anatomy: Comparison of two different devices (Amplatzer Septal Occluder device and Amplatzer PFO Occluder device 30/35)

21. Percutaneous Left Atrial Appendage Occlusion: An Emerging Option in Patients with Atrial Fibrillation at High Risk of Bleeding

22. Fluid challenge and balloon occlusion testing in patients with atrial septal defects

23. Effects of colchicine on tissue factor in oxLDL-activated T-lymphocytes

24. Colchicine inhibits the prothrombotic effects of oxLDL in human endothelial cells

25. Repetitive levosimendan in outpatients affected by advanced heart failure: the need for a uniform approach

26. Atrial Fibrillation in COVID-19: From Epidemiological Association to Pharmacological Implications

27. Edoxaban in elderly patient with morbid obesity and atrial fibrillation: the role of plasma levels evaluation for selecting the appropriate dose

28. Risk reduction and right heart reverse remodeling by upfront triple combination therapy in pulmonary arterial hypertension

29. Oxidized low-density lipoproteins induce tissue factor expression in T-lymphocytes via activation of lectin-like oxidized low-density lipoprotein receptor-1

30. Vitamin D inhibits Tissue Factor and CAMs expression in oxidized low-density lipoproteins-treated human endothelial cells by modulating NF-κB pathway

31. Population Trends in Rates of Percutaneous Coronary Revascularization for Acute Coronary Syndromes Associated with the COVID-19 Outbreak

32. Update on Direct Oral Anticoagulants in Atrial Fibrillation Patients Undergoing Cardiac Interventional Procedures: From Clinical Trials to Real-World Evidence

33. Effect of Sacubitril-Valsartan in reducing depression in patients with advanced heart failure

34. Direct Oral Anticoagulants in Octogenarians With Atrial Fibrillation: It Is Never Too Late

35. Safety and Efficacy of Triple Antithrombotic Therapy with Dabigatran versus Vitamin K Antagonist in Atrial Fibrillation Patients: A Pilot Study

36. Complete resolution of left atrial appendage thrombosis with oral dabigatran etexilate in a patient with Myotonic Dystrophy type 1 and atrial fibrillation

37. Left atrial myocardial dysfunction after chronic abuse of anabolic androgenic steroids: a speckle tracking echocardiography analysis

38. Does cardiac pacing reduce syncopal recurrences in cardioinhibitory vasovagal syncope patients selected with head-up tilt test? Analysis of a 5-year follow-up database

39. Ambulatory dynamic Holter monitoring: a practical guide to appropriate use and reporting in clinical cardiology

40. Updated clinical indications for transcatheter aortic valve implantation in patients with severe aortic stenosis: Expert opinion of the Italian Society of Cardiology and GISE

41. Colchicine reduces platelet aggregation by modulating cytoskeleton rearrangement via inhibition of cofilin and LIM domain kinase 1

42. Relationship between Pregnancy-associated Plasma Protein-A and tissue factor levels in the coronary circulation of patients with acute coronary syndrome

43. Lights and shadows of long-term dual antiplatelet therapy in 'real life' clinical scenarios

44. Splicing of platelet resident pre-mRNAs upon activation by physiological stimuli results in functionally relevant proteome modifications

45. Fluid challenge predicts clinical worsening in pulmonary arterial hypertension

46. Use of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients with Malignancy: Clinical Practice Experience in a Single Institution and Literature Review

47. Atrial Fibrillation and Malignancy: The Clinical Performance of Non-Vitamin K Oral Anticoagulants-A Systematic Review

48. Role of Tissue Factor in the Coagulation Network

49. Reactive oxygen species induce a procoagulant state in endothelial cells by inhibiting tissue factor pathway inhibitor

50. Efficacy and safety of dabigatran in patients with atrial fibrillation scheduled for transoesophageal echocardiogram-guided direct electrical current cardioversion: a prospective propensity score-matched cohort study

Catalog

Books, media, physical & digital resources